We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAIN icon
1401
Main Street Capital
MAIN
$5.48B
– –
-800
Closed -$30K
MAN icon
1402
ManpowerGroup
MAN
$2.63B
– –
-900
Closed -$74K
MAR icon
1403
Marriott International
MAR
$92.3B
– –
-3,106
Closed -$389K
MAS icon
1404
Masco
MAS
$15.3B
– –
-801,995
Closed -$31.5M
MATV icon
1405
Mativ Holdings
MATV
$711M
– –
-300
Closed -$12K
MATW icon
1406
Matthews International
MATW
$739M
– –
-4,205
Closed -$156K
MBI icon
1407
MBIA
MBI
$260M
– –
-1,283
Closed -$12K
MBUU icon
1408
Malibu Boats
MBUU
$567M
– –
-30,299
Closed -$1.2M
MCB icon
1409
Metropolitan Bank Holding Corp
MCB
$1.15B
– –
-2,867
Closed -$99K
MCK icon
1410
McKesson
MCK
$101B
– –
-2,800
Closed -$328K
MCS icon
1411
Marcus Corp
MCS
$945M
– –
-2,462
Closed -$99K
MDGL icon
1412
Madrigal Pharmaceuticals
MDGL
$11.8B
– –
-141,301
Closed -$17.7M
MDT icon
1413
Medtronic
MDT
$112B
– –
-499,191
Closed -$45.5M
MDU icon
1414
MDU Resources
MDU
$4.32B
– –
-4,734
Closed -$46K
MED icon
1415
Medifast
MED
$141M
– –
-2,556
Closed -$326K
MEOH icon
1416
Methanex
MEOH
$4.12B
– –
-89,179
Closed -$5.07M
MET icon
1417
MetLife
MET
$62.1B
– –
-138,648
Closed -$5.9M
MFIC icon
1418
MidCap Financial Investment
MFIC
$804M
– –
-31,161
Closed -$472K
MGNX icon
1419
MacroGenics
MGNX
$257M
– –
-3,260
Closed -$59K
MGY icon
1420
Magnolia Oil & Gas
MGY
$5.94B
– –
-2,000
Closed -$24K
MHK icon
1421
Mohawk Industries
MHK
$9.22B
– –
-675
Closed -$85K
MKC icon
1422
McCormick & Company Non-Voting
MKC
$14.2B
– –
-3,000
Closed -$226K
MKL icon
1423
Markel Group
MKL
$23.2B
– –
-80
Closed -$80K
MLM icon
1424
Martin Marietta Materials
MLM
$33B
– –
-309
Closed -$62K
MRSH
1425
Marsh
MRSH
$91.5B
– –
-1,993
Closed -$187K
55 56
57
58 59

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.